Huang used 83 cancer cell lines derived from hematologic malignancies, breast cancer, liver cancer, pancreatic cancer, and lung cancer, most of which had high levels of EZH2 expression (Huang et al., 2018). The gene discussed is EZH2; the disease is liver cancer.